Comparison
IGF-1 DES vs IGF-1 LR3
Site-specific pulse vs. systemic long-acting IGF-1 analog — ultra-targeted growth vs. full-body anabolic signaling.
This page contains affiliate links to compounds sold strictly for laboratory research use only. We may earn a commission on qualifying purchases at no additional cost to you. See our affiliate policy.
Effectiveness Profile
IGF-1 DES
IGF-1 LR3
At a Glance
| IGF-1 DES | IGF-1 LR3 | |
|---|---|---|
| Type | GH & IGF | GH & IGF |
| Legal status | Research | Research |
| Half-life | 20–30 minutes | 20–30 hours |
| Preferred route | IM (site-specific) | SubQ |
| Dose frequency | once-daily | once-daily |
| Beginner dose | 20–50 mcg | 20–40 mcg |
| Intermediate dose | 50–100 mcg | 40–80 mcg |
| Advanced dose | 100–200 mcg | 80–120 mcg |
| Cycle length | 4–6 wks | 3–6 wks |
| Bioavailability | 80% | 90% |
| Time to peak | 0.4h | 2h |
| Active duration | 2h | 24h |
| Storage | 2–8°C refrigerated; lyophilized vials frozen for long-term storage; reconstituted vials used within 3–4 weeks | 2–8°C refrigerated; freeze aliquots for long-term storage. Acetic-acid reconstitution preferred over bac water past 2 weeks. |
| PCT required | No | No |
| Ancillaries required | No | No |
| Safe for women | Yes | Yes |
Verdict
IGF-1 DES wins for:
- Ultra-precise, site-specific hypertrophy when localized growth or repair is the goal
- Short half-life ideal for targeted pre-workout/peri-training use
- Lower systemic exposure, reducing off-target hypoglycemia risk
- Rapid acute effect, useful for lagging muscle specialization blocks or injury support
IGF-1 LR3 wins for:
- Sustained, systemic IGF-1R activation supporting whole-body growth and nutrient repartitioning
- Once-daily or even every-other-day SubQ protocols maximizing convenience
- Clear synergy as part of the classic GH/insulin/IGF-1 "trinity" stack
- Greater overall muscle gain potential in 3–6 week pulses (when paired with carbs and proper timing)
Pick A or B?
Pick IGF-1 DES if:
- The research aim is correcting lagging, asymmetric, or stubborn muscle groups
- Site injection with a potent, short-acting peptide is preferred
- The goal is maximizing local satellite-cell activation post-training (e.g., in targeted specialization blocks)
- Managing hypoglycemia and systemic exposure is a priority
- The subject is recovering from a minor muscle/tendon injury and needs focused repair
Pick IGF-1 LR3 if:
- Full-body hypertrophy, recovery, or partitioning is the goal in a 3–6 week pulse
- Research priorities include stacking GH, insulin, and IGF-1 analogs in a proven synergy
- Daily SubQ administration is a more convenient protocol
- The cycle calls for maximizing systemic IGF-1 action with minimal protocol complexity
- Favoring established dosing protocols and more widely available supply chains
Where to Buy
Swiss Chems
Ships from US
Affiliate link — we may earn a commission at no cost to you.
Use code-10%
BIOMOGGING- IGF-1 LR3· Buy IGF-1 LR3 1mg - SwissChems - Buy Best Quality Peptides, SARMS OnlineBuy IGF-1 LR3
Real Peptides
Ships from USLogin Required
Affiliate link — we may earn a commission at no cost to you.
Use code-20%
BioMogging20- IGF-1 LR3· IGF-1 LR3Buy IGF-1 LR3
This comparison is presented for informational and educational purposes only. The compounds described may be research chemicals, prescription-only, or regulated substances in your jurisdiction. Consult a qualified medical professional before using any compound. This is not medical advice.